El mercado de alimentos medicinales para errores congénitos del metabolismo se valoró en 2.507,80 millones de dólares en 2019 y se prevé que alcance los 5.768,79 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 11,2% entre 2020 y 2027.
Los alimentos medicinales se refieren al tipo especializado de alimentos formulados para ser consumidos bajo supervisión médica y destinados al control dietético específico de una enfermedad en particular. o condición. Estas condiciones médicas generalmente tienen requisitos nutricionales distintivos basados en principios científicos y reconocidos que se establecen mediante evaluación médica. La comida medicinal se diferencia de las drogas; sin embargo, están destinados al consumo bajo supervisión médica como intervención primaria. Cuando se identifica a los bebés con errores congénitos del metabolismo, generalmente se les prescribe una dieta especial adecuada a su condición particular que debe seguir durante toda la vida. El crecimiento del mercado mundial de alimentos médicos para errores congénitos del metabolismo se atribuye a la creciente incidencia de errores congénitos del metabolismo y a la creciente preferencia por los complementos alimenticios dietéticos. Sin embargo, las limitaciones asociadas a los alimentos médicos para errores congénitos del metabolismo son el principal factor que obstaculiza el crecimiento del mercado.
Se espera que el mercado mundial de alimentos médicos para errores congénitos del metabolismo presenciar un crecimiento sustancial después de la pandemia. El COVID-19 ha afectado a las economías e industrias de varios países debido a cierres, prohibiciones de viaje y cierres de empresas. La crisis de la COVID-19 ha sobrecargado los sistemas de salud pública en muchos países y ha puesto de relieve la gran necesidad de realizar inversiones sostenibles en los sistemas de salud. A medida que avanza la pandemia de COVID-19, se espera que la industria de la salud experimente una caída en su crecimiento. El segmento de ciencias biológicas prospera debido a la mayor demanda de productos de diagnóstico in vitro y al aumento de las actividades de investigación y desarrollo en todo el mundo. Sin embargo, el segmento de tecnologías médicas e imágenes está experimentando una caída en las ventas debido a un menor número de cirugías realizadas y a retrasos o prolongaciones en la adquisición de equipos. Además, se espera que las consultas virtuales realizadas por profesionales de la salud se conviertan en el modelo principal de prestación de atención después de la pandemia. Dado que la telesalud está transformando la prestación de atención, la salud digital seguirá prosperando en los próximos años. Además, también se espera que la interrupción de los ensayos clínicos y el consiguiente retraso en el lanzamiento de medicamentos allanen el camino para ensayos totalmente virtuales en el futuro. Se espera que surjan nuevas tecnologías como el ARNm y que cambien la industria farmacéutica y también se espera que el mercado sea testigo de una mayor integración vertical y empresas conjuntas en los próximos años.
regiones lucrativas para el mercado mundial de alimentos medicinales para errores congénitos del metabolismo
< /p>
Perspectivas del mercado
Creciente preferencia hacia los suplementos dietéticos para impulsar el crecimiento del mercado mundial de alimentos médicos para errores congénitos del metabolismo
Las tasas de consumo de suplementos nutracéuticos y alimentos médicos recetados están aumentando con respecto a los medicamentos terapéuticos basados en enzimas. Es probable que los crecientes costos de la atención médica y la creciente preferencia de los consumidores por remedios simples y efectivos para el manejo de enfermedades sean responsables del cambio de linaje de medicamentos a suplementos médicos y alimentos nutricionales. Los alimentos medicinales se refieren a una categoría de productos que se utilizan en el tratamiento dietético de diversas enfermedades, incluidos errores congénitos del metabolismo, que contienen nutrientes específicos para satisfacer las necesidades nutricionales de pacientes que padecen afecciones particulares.
The US Food and Drug (FDA) ha clasificado los alimentos médicos en cuatro categorías principales: fórmulas para trastornos metabólicos, productos nutricionales completos, productos nutricionalmente incompletos y soluciones de rehidratación oral.
Es fácil acceder a los alimentos médicos ya que lo hacen. No requieren receta médica pero necesariamente se consumen bajo control médico. En caso de errores congénitos del metabolismo, los alimentos medicinales se utilizan como opciones de tratamiento, y los productos disponibles en el mercado están regulados por estados autorizados y reglamentarios de alimentos y suplementos dietéticos. El tratamiento nutricional para los errores congénitos del metabolismo proporciona entre el 85% y el 90% de las necesidades nutricionales de una persona que padece un determinado trastorno hereditario. Además, los efectos secundarios de estos suplementos son casi insignificantes, lo que los hace ideales para el consumo de pacientes de todas las edades. En los últimos años, las aseguradoras médicas privadas de EE.UU. y algunos otros países también ofrecen programas de reembolso por el consumo de ciertos alimentos médicos. Por lo tanto, se espera que la creciente adopción de alimentos médicos y suplementos nutritivos fomente el crecimiento del mercado en los próximos años.
Información basada en productos
En términos de tipo de producto, el mercado mundial de alimentos médicos para errores congénitos del metabolismo se segmenta en aminoácidos, glicactina con GMP, fórmula infantil modificada con aminoácidos con hierro, fórmula infantil baja en calcio/vitamina D con hierro, alimentos bajos en proteínas. y otros. En 2019, el segmento de aminoácidos tuvo la mayor participación del mercado. Además, se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
Mercado global de alimentos médicos para errores congénitos del metabolismo, por producto– 2019 y 2027
Perspectivas basadas en grupos de edad
En términos de grupo de edad, el El mercado mundial de alimentos médicos para errores congénitos del metabolismo está segmentado en bebés, destetes, adolescentes y adultos. En 2019, el segmento infantil tuvo la mayor cuota de mercado. Además, se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
Información basada en enfermedades
Basado en las enfermedades, el mercado global El mercado de alimentos médicos para errores congénitos del metabolismo se segmenta en fenilcetonuria (PKU), enfermedad de la orina con jarabe de arce (MSUD), homocistonuria, trastornos del ciclo de la urea, academia metilmelónica, acidureas orgánicas, academia propiónica, academia isovalérica, trastornos del metabolismo de la leucina, tipo académico glutárico. -1, enfermedad renal, tirosinemia tipos I y II y otras. El segmento de fenilcetonuria tuvo la mayor participación de mercado en 2019. Sin embargo, se espera que el segmento de academia glutárica tipo 1 crezca al ritmo más rápido durante los próximos años.
Información basada en formularios
Basado en formularios, el mercado mundial de alimentos médicos para errores congénitos del metabolismo se segmenta en polvo, líquidos, geles, y otros. El segmento de polvo tuvo la mayor participación de mercado en 2019. Además, se estima que el mismo segmento crecerá al CAGR más alto durante el período de pronóstico.
Información basada en empaques< /h3>
En términos de envasado, el mercado mundial de alimentos médicos para errores congénitos del metabolismo se segmenta en latas, frascos, paquetes, botellas y otros. El segmento de latas tuvo la mayor participación del mercado en 2019. Sin embargo, se espera que el segmento de paquetes crezca al CAGR más alto durante el período de pronóstico.
Canal de distribución: Información basada en
En términos de canal de distribución, el mercado mundial de alimentos médicos para errores congénitos del metabolismo se segmenta en farmacias minoristas, farmacias hospitalarias, farmacias en línea, droguerías y otros. El segmento de farmacias minoristas tuvo la mayor participación del mercado en 2019. Además, se estima que el mismo segmento crecerá al ritmo más rápido durante el período de pronóstico.
Perspectivas estratégicas
Los actores del mercado global de alimentos médicos para errores congénitos del metabolismo están adoptando estrategias de lanzamiento y expansión de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
< p>Mercado global de alimentos medicinales para errores innatos del metabolismo: por producto
- Aminoácido
- Glicactina con GMP
- Fórmula infantil modificada con aminoácidos y hierro
- Baja en calcio/ Fórmula infantil sin vitamina D con hierro
- Alimentos bajos en proteínas
- Otros
Mercado global de alimentos medicinales para errores congénitos del metabolismo: por grupo de edad
- Bebés
- Destete
- Adolescentes
- Adultos
Mercado global de alimentos medicinales para errores innatos del metabolismo: por enfermedad
- Fenilcetonuria (PKU)
- Enfermedad de la orina con jarabe de arce (MSUD)
- Homocistinuria
- Trastornos del ciclo de la urea
- Acidemia metilmalónica
- Acideurias orgánicas
- Acidemia propiónica
- AciDemia isovalérica
- Trastornos del metabolismo de la leucina < li>Acidemia glutárica tipo I
- Enfermedad renal
- Tirosinemia tipos I y II
- Otros
Alimentos médicos globales para Errores innatos del mercado del metabolismo – por Formas
- Polvo
- Líquido
- Geles
- Otros
Global Medical Mercado de alimentos para errores innatos del metabolismo: por Embalaje
- Lata
- Tarro
- Paquetes
- Botella
- Otros
Mercado global de alimentos medicinales para errores congénitos del metabolismo: por Canal de Distribución
- Farmacias Minoristas
- Farmacias Hospitalarias
- Farmacias Online
- Farmacias
- Otros< /li>
Mercado global de alimentos medicinales para errores congénitos del metabolismo: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- Suramérica y Centroamérica (SCAM)
- Brasil
- Argentina
- Resto de SCAM
< /ul> - Nestléé Ciencias de la salud
- Abbott
- Reckitt Benckiser Group Plc
- Ajinomoto Cambrooke, Inc.
- Solace Nutrition
- Primus Pharmaceuticals, Inc.
- BioMarin Pharmaceutical
- Danone SA
- Galen Limited
- PKU-MDmil
Perfiles de la empresa
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Medical food refers to the specialized kind of food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable to their particular condition that must be followed for the lifetime.
Factors such as increasing incidence of inborn errors of metabolism and increasing preference towards dietary food supplements are expected to boost the growth of the global medical foods for inborn errors of metabolism market. However, the market is likely to get impacted by the limitations associated to medical foods for inborn errors of metabolism during the forecast period.
North America is the largest market for the medical foods for inborn errors of metabolism market. The factors that are responsible for the dominance of the region include rising government support well-developed healthcare facilities, presence of top market players, increasing number of patients with inborn errors of metabolism and rising awareness regarding benefits of consuming nutritional supplements under medical supervision. Similarly, in Canada, increasing government initiatives to raise awareness regarding rare genetic disorders and well-established healthcare infrastructure are leading to market growth. Asia-Pacific is anticipated to register as the fastest-growing region in the global medical foods for inborn errors of metabolism market. The growth of the market is expected to be fastest in countries such as China, India, and Japan. The factors that are expected to drive the market growth include large number of patients suffering with genetic diseases and increasing launch of innovative products by local players in the Asian countries. Increasing collaborations and partnerships are also responsible for the growth of the market in the Asian region.
The List of Companies - Medical Foods for Inborn Errors of Metabolism Market
- Nestlé Health Science
- Nutricia
- Solace Nutrition
- Abbott
- Mead Johnson and Company, LLC.
- BioMarin Pharmaceutical
- Ajinomoto Cambrooke, Inc.
- Poa Pharma
- PKU-MDmil
- Primus Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)